FDA Import Refusal SCS-4498917-3/10002/1 — ARAMEX- TRANSIT
The FDA refused shipment SCS-4498917-3/10002/1 from ARAMEX- TRANSIT (United Kingdom) on July 7, 2026. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charge: 27 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- July 7, 2026
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY74 TIRZEPATIDE (ANTI-DIABETIC)
- Charges
- 27